Literature DB >> 23508431

Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India.

N Sinha1, J Agarwal, S Srivastava, M Singh.   

Abstract

Multidrug-resistant (MDR) Acinetobacter baumannii is a worldwide concern as cause of serious nosocomial infections. We analysed 140 non-duplicate Acinetobacter sp. isolates from hospitalised patients in a tertiary care centre; 87% were MDR and 20% (28/140) meropenem resistant. Metallo-β-lactamase was produced by 16 of these, detected by ethylene-diamine-tetra-acetic acid disc synergy test. AmpC β-lactamase and efflux pump were present in 17 and 4 of the meropenem-resistant Acinetobacter, respectively. 9/16 MBL-positive isolates carried genes for carbapenem resistance as shown by polymerase chain reaction.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23508431     DOI： 10.4103/0255-0857.108724

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN： 0255-0857            Impact factor:   0.985


  9 in total

1.  Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.

Authors:  Sangeetha Rajenderan; Veeraraghavan Balaji; Shalini Anandan; Rani Diana Sahni; Giannoula S Tansarli; Matthew E Falagas
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 2.  Coexistence of Extended Spectrum Beta-Lactamases, AmpC Beta-Lactamases and Metallo-Beta-Lactamases in Acinetobacter baumannii from burns patients: a report from a tertiary care centre of India.

Authors:  V Gupta; R Garg; S Garg; J Chander; A K Attri
Journal:  Ann Burns Fire Disasters       Date:  2013-12-31

3.  A decade of change in susceptibility patterns of Gram-negative blood culture isolates: a single center study.

Authors:  Murali Alagesan; Ram Gopalakrishnan; Senthur Nambi Panchatcharam; Sureshkumar Dorairajan; Thirunarayan Mandayam Ananth; Ramasubramanian Venkatasubramanian
Journal:  Germs       Date:  2015-09-01

4.  Nosocomial Acinetobacter baumannii Infections and Changing Antibiotic Resistance.

Authors:  Ismail Necati Hakyemez; Abdulkadir Kucukbayrak; Tekin Tas; Aslihan Burcu Yikilgan; Akcan Akkaya; Aliye Yasayacak; Hayrettin Akdeniz
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

5.  Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study.

Authors:  Musaed Saad Al Samawi; Fahmi Yousef Khan; Yasser Eldeeb; Muna Almaslamani; Abdullatif Alkhal; Hussam Alsoub; Wissam Ghadban; Faraj Howady; Samar Hashim
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-28       Impact factor: 2.471

6.  Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes.

Authors:  Gisela Di Venanzio; Ana L Flores-Mireles; Juan J Calix; M Florencia Haurat; Nichollas E Scott; Lauren D Palmer; Robert F Potter; Michael E Hibbing; Laura Friedman; Bin Wang; Gautam Dantas; Eric P Skaar; Scott J Hultgren; Mario F Feldman
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

7.  Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Subhasree Roy; Vivek Junghare; Shanta Dutta; Saugata Hazra; Sulagna Basu
Journal:  mSystems       Date:  2022-06-23       Impact factor: 7.324

8.  Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India.

Authors:  Dabet Rynga; Malini Shariff; Monorama Deb
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-04       Impact factor: 3.944

Review 9.  The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy.

Authors:  Natalia Bagińska; Martyna Cieślik; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Antibiotics (Basel)       Date:  2021-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.